The more efficient priming of CD4 naive T cells by Omicron BA.1-stimulated pDC compared to Delta-stimulated pDC, shown in this study, may partially account for the above-mentioned difference in the severity of COVID-19 that depends on the SARS-CoV-2 variant. This evidence concerns the gene CD4 and COVID-19.